VSTM.NASDAQVerastem, INC

SCHEDULE: Stonepine Discloses 5% Stake in Verastem

Sentiment:

Beneficial Ownership Disclosure


Stonepine Capital entities and Jon M. Plexico have disclosed a 5.0% beneficial ownership stake in Verastem, Inc., totaling 2,833,333 shares.

Summary

  • Stonepine Capital Management, LLC, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico collectively reported beneficial ownership of 2,833,333 shares of Verastem, Inc. Common Stock.
  • This ownership represents 5.0% of Verastem, Inc.'s outstanding Common Stock.
  • The reported beneficial ownership includes 1,500,000 shares of Common Stock and 1,333,333 shares of Common Stock underlying warrants.
  • The percentage of class was calculated based on 54,949,170 shares of Common Stock outstanding as of May 12, 2025, as reported in Verastem's Form 10-Q for the quarter ended March 31, 2025.
  • The reporting persons share both voting and dispositive power over all 2,833,333 shares.
  • The securities were not acquired and are not held for the purpose of changing or influencing the control of Verastem, Inc.

Sentiment

Score: 5

Explanation: The filing is a standard disclosure of beneficial ownership, indicating a passive investment. It does not contain information that would inherently suggest positive or negative sentiment regarding the company's performance or prospects.

Positives

  • NA

Negatives

  • NA

Risks

  • Each reporting person disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein.
  • The filing on behalf of Stonepine Capital, L.P. should not be construed as an admission that it is a beneficial owner, as defined in Rule 13d-3 under the Securities Exchange Act of 1934, of any Common Stock covered by this Schedule 13G.

Future Outlook

NA

Industry Context

This filing indicates a passive investment by Stonepine Capital entities in Verastem, Inc., a common occurrence in the public markets where investment firms acquire stakes in companies for portfolio diversification or long-term value appreciation. It does not suggest any specific industry trend or competitive action.

Related Party Transactions

  • Stonepine Capital Management, LLC is the investment adviser to Stonepine Capital, L.P.
  • Stonepine GP, LLC is the general partner of Stonepine Capital, L.P.
  • Jon M. Plexico is the control person of Stonepine Capital Management, LLC and Stonepine GP, LLC.

Stakeholder Impact

  • Shareholders gain transparency regarding a significant institutional holder's stake in the company, which can influence market perception and trading activity.

Key Dates

DateDescription
2024-10-10Date of Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G
2025-03-31End of quarter for which Verastem's Form 10-Q was filed, reporting outstanding shares
2025-05-12Date as of which 54,949,170 shares of Common Stock were outstanding, as reported in Verastem's Form 10-Q
2025-07-22Date of event which requires filing of this statement
2025-08-05Date of signing of the Schedule 13G filing

Keywords

Verastem, Stonepine Capital, beneficial ownership, Schedule 13G, common stock, warrants, institutional ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.